What products does Biogen Idec offer?

Biogen Idec offers a diverse range of products geared towards treating neurological and autoimmune disorders. Our extensive product portfolio includes innovative therapies for multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and spinal muscular atrophy (SMA). Our flagship multiple sclerosis products include TECFIDERA®, an oral therapy, and AVONEX®, a leading interferon beta therapy. For individuals with spinal muscular atrophy, we have SPINRAZA®, the first and only approved treatment option. Moreover, Biogen Idec provides PLEGRIDY®, which offers an alternative treatment for relapsing-remitting MS. Additionally, we offer ZINBRYTA®, an innovative treatment for adults with relapsing forms of MS. Our commitment to advancing medical breakthroughs enables us to offer patients a wide range of products to address their specific needs across various neurological and autoimmune conditions.